» Articles » PMID: 8829493

Effect of Prophylactic Benzathine Penicillin on Mucocutaneous Symptoms of Behçet's Disease

Overview
Journal Dermatology
Publisher Karger
Specialty Dermatology
Date 1996 Jan 1
PMID 8829493
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies point out a probable role of streptococcal antigens in the pathogenesis of Behçet's disease (BD). This has led to the proposal of benzathine penicillin as a therapeutic modality in BD.

Objective: A prospective study was conducted to compare the efficacy of colchicine and colchicine + benzathine penicillin treatments on mucocutaneous manifestations of BD.

Methods: 60 patients (group I) were given colchicine alone and 94 (group II) were given colchicine + benzathine penicillin. Frequency, number, duration and severity of oral aphthous ulcers, genital ulcers and erythema nodosum were determined before and after treatment.

Results: In group I, all parameters of oral ulcers and the frequency and healing time of genital ulcers and erythema nodosum decreased significantly. In group II, all parameters of oral aphthous ulcers, genital ulcers and erythema nodosum were significantly improved. When treatment results in the two groups were compared, the decrements in the frequency and duration of oral ulcers and erythema nodosum and the frequency of genital ulcers were significantly greater in group II than in group I (p < 0.05).

Conclusion: We conclude that prophylactic benzathine penicillin combined with colchicine is more effective in controlling mucocutaneous manifestations of BD than colchicine alone.

Citing Articles

The clinical manifestations and treatment outcomes of Behçet's disease: A single-center experience.

Hama Hussein K, Abdullah H, Ahmed S, Qadir A, Asaad H, Fattah F Health Sci Rep. 2024; 7(7):e2238.

PMID: 39055614 PMC: 11269204. DOI: 10.1002/hsr2.2238.


Enthesitis as an initial presentation of vascular Behçet's syndrome: a case-based review.

Saito I, Shirai T, Sato H, Ishii T, Fujii H Rheumatol Int. 2024; 44(11):2637-2643.

PMID: 38713409 DOI: 10.1007/s00296-024-05607-3.


Heat Shock Proteins in Behçet Syndrome.

Kirectepe Aydin A, Hatemi G Balkan Med J. 2023; 40(5):314-323.

PMID: 37525514 PMC: 10500141. DOI: 10.4274/balkanmedj.galenos.2023.2023-6-76.


Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.

Kim D, Nakamura K, Kaneko F, Alpsoy E, Bang D Front Med (Lausanne). 2022; 9:987393.

PMID: 36530905 PMC: 9755684. DOI: 10.3389/fmed.2022.987393.


Oral Health and Its Aetiological Role in Behçet's Disease.

Mumcu G, Fortune F Front Med (Lausanne). 2021; 8:613419.

PMID: 34095159 PMC: 8172597. DOI: 10.3389/fmed.2021.613419.